Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms

Endothelial cell infection and endotheliitis in COVID-19

Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358 · see citing works

Neurologic features in severe SARS-CoV-2 infection

Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674 · see citing works

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., Leacy, R. A. D., Shigematsu, T., Ladner, T. R., Yaeger, K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,114 · see citing works

A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

Moriguchi, T., Harii, N., Goto, J., Harada, D., Sugawara, H., Takamino, J., Ueno, M., Sakata, H., Kondo, K., Myose, N., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.062 · Cited by 2,024 · see citing works

Multiorgan and Renal Tropism of SARS-CoV-2

Puelles, V. G., Lütgehetmann, M., Lindenmeyer, M. T., Sperhake, J. P., Wong, M. N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2011400 · Cited by 1,775 · see citing works

Frontal encephalopathy related to hyperinflammation in COVID-19

Cani, I., Barone, V., D’Angelo, R., Pisani, L., Allegri, V., Spinardi, L., Malpassi, P., Fasano, L., Rinaldi, R., Fanti, S., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10057-5 · Cited by 43 · see citing works

Guillain–Barré syndrome in the COVID-19 era: another occasional cluster?

Tatu, L., Nono, S., Grácio, S., & Koçer, S. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10005-3 · Cited by 32 · see citing works

SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids

Pellegrini, L., Albecka, A., Mallery, D. L., Kellner, M. J., Paul, D., Carter, A. P., James, L. C., & Lancaster, M. A. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.10.001 · Cited by 546 · see citing works

High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms

Franke, C., Ferse, C., Kreye, J., Reincke, S. M., Sánchez-Sendín, E., Rocco, A., Steinbrenner, M., Angermair, S., Treskatsch, S., Zickler, D., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.022 · Cited by 275 · see citing works

Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome

Komaroff, A. L., & Lipkin, W. I. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.06.002 · Cited by 266 · see citing works

Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms

Song, E., Bartley, C. M., Chow, R. D.-W., Ngo, T. T., Jiang, R., Zamecnik, C. R., Dandekar, R., Loudermilk, R. P., Dai, Y., Liu, F., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100288 · Cited by 212 · see citing works

COVID-19 vasculitis and novel vasculitis mimics

McGonagle, D., Bridgewood, C., Ramanan, A. V., Meaney, J. F. M., & Watad, A. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30420-3 · Cited by 192 · see citing works

Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid

Heming, M., Li, X., Räuber, S. J., Mausberg, A. K., Börsch, A., Hartlehnert, M., Singhal, A., Lu, I., Fleischer, M., Szepanowski, F., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.12.011 · Cited by 179 · see citing works

Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword

Tan, L. Y., Komarasamy, T. V., & Balasubramaniam, V. R. M. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742941 · Cited by 176 · see citing works

COVID-19 associated cognitive impairment: A systematic review

Tavares-Júnior, J. W. L., de Souza, A. C. C., Borges, J. W. P., Oliveira, D. N., Neto, J. I. S., Sobreira-Neto, M. A., & Braga‐Neto, P. (2022) · Cortex · doi:10.1016/j.cortex.2022.04.006 · Cited by 179 · see citing works

Cerebrospinal fluid in COVID-19: A systematic review of the literature

Lewis, A. K., Frontera, J. A., Placantonakis, D. G., Lighter, J., Galetta, S. L., Balcer, L. J., & Melmed, K. R. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117316 · Cited by 165 · see citing works

COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance

Achar, A., & Ghosh, C. (2020) · Cells · doi:10.3390/cells9112360 · Cited by 159 · see citing works

Neurological complications and infection mechanism of SARS-CoV-2

Wan, D., Du, T., Hong, W., Chen, L., Que, H., Lu, S., & Peng, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00818-7 · Cited by 132 · see citing works

The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models

Butowt, R., Meunier, N., Bryche, B., & von Bartheld, C. S. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02314-2 · Cited by 122 · see citing works

Neuropathology of COVID-19 (neuro-COVID): clinicopathological update

Lou, J. J., Movassaghi, M., Gordy, D. E., Olson, M. G., Zhang, T., Khurana, M. S., Chen, Z., Perez-Rosendahl, M. A., Thammachantha, S., Singer, E. J., et al. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2021-2993 · Cited by 117 · see citing works

Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study

Etter, M. M., Martins, T. A., Kulsvehagen, L., Pössnecker, E., Duchemin, W., Hogan, S. A., Sanabria-Díaz, G., Müller, J., Chiappini, A., Rychen, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34068-0 · Cited by 106 · see citing works

Cognitive decline following acute viral infections: literature review and projections for post-COVID-19

Damiano, R. F., Guedes, B. F., de Rocca, C. C., de Pádua Serafim, A., Castro, L. H. M., Munhoz, C. D., Nitrini, R., Filho, G. B., Miguel, E. C., Lucchetti, G., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01286-4 · Cited by 98 · see citing works

Acute and Post-Acute Neurological Complications of COVID-19

Al-Ramadan, A., Rabab’h, O., Shah, J., & Gharaibeh, A. (2021) · Neurology International · doi:10.3390/neurolint13010010 · Cited by 97 · see citing works

Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID ‐19

Apple, A. C., Oddi, A., Peluso, M. J., Asken, B. M., Henrich, T. J., Kelly, J. D., Pleasure, S. J., Deeks, S. G., Allen, I. E., Martin, J. N., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51498 · Cited by 87 · see citing works

COVID ‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era

Taga, A., & Lauria, G. (2022) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12482 · Cited by 87 · see citing works

Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses

Rabaan, A. A., Al-Ahmed, S. H., Garout, M. A., Al‐Qaaneh, A. M., Sule, A. A., Tirupathi, R., Mutair, A. S. A., Alhumaid, S., Hasan, A., Dhawan, M. K., et al. (2021) · Pathogens · doi:10.3390/pathogens10050565 · Cited by 84 · see citing works

Neuropsychiatric complications of covid-19

Butler, M., Pollak, T. A., Rooney, A. G., Michael, B. D., & Nicholson, T. R. (2020) · BMJ · doi:10.1136/bmj.m3871 · Cited by 83 · see citing works

Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms

Johansson, A., Mohamed, M. S., Moulin, T. C., & Schiöth, H. B. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577658 · Cited by 78 · see citing works

Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm

Garcia, M. A., Barreras, P., Lewis, A., Pinilla-Monsalve, G. D., Sokoll, L. J., Kickler, T. S., Mostafa, H. H., Caturegli, M., Moghekar, A., Fitzgerald, K. C., et al. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117517 · Cited by 79 · see citing works

Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients

Remsik, J., Wilcox, J. A., Babady, N. E., McMillen, T. A., Vachha, B. A., Halpern, N. A., Dhawan, V., Rosenblum, M., Iacobuzio-Donahue, C. A., Avila, E. K., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.007 · Cited by 77 · see citing works

Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients

Ermis, U., Rust, M. I., Bungenberg, J., Costa, A. S., Dreher, M., Balfanz, P., Marx, G., Wiesmann, M., Reetz, K., Tauber, S. C., et al. (2021) · Neurological Research and Practice · doi:10.1186/s42466-021-00116-1 · Cited by 73 · see citing works

Status epilepticus and COVID-19: A systematic review

Dono, F., Nucera, B., Lanzone, J., Evangelista, G., Rinaldi, F., Speranza, R., Troisi, S., Tinti, L., Russo, M., Pietro, M. D., et al. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.107887 · Cited by 67 · see citing works

Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients

Lersy, F., Benotmane, I., Helms, J., Collange, O., Schenck, M., Brisset, J., Chammas, A., Willaume, T., Lefèbvre, N., Solis, M., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa745 · Cited by 61 · see citing works

Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms

Edén, A., Grahn, A., Bremell, D., Aghvanyan, A., Bathala, P., Fuchs, D., Gostner, J. M., Hagberg, L., Kanberg, N., Kanjananimmanont, S., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.13253 · Cited by 59 · see citing works

Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry

García‐Azorín, D., Abildúa, M. J. A., Aguirre, M. E. E., Fernández, S. F., Moncó, J. C. G., Guijarro-Castro, C., González-Platas, M., Delgado, F. R., Andrés, J. M. L., Ezpeleta, D., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117283 · Cited by 50 · see citing works

Long-Term Brain Disorders in Post Covid-19 Neurological Syndrome (PCNS) Patient

Nuzzo, D., Cambula, G., Bacile, I., Rizzo, M., Galia, M., Mangiapane, P., Picone, P., Giacomazza, D., & Scalisi, L. (2021) · Brain Sciences · doi:10.3390/brainsci11040454 · Cited by 50 · see citing works

MOG-associated encephalitis following SARS-COV-2 infection

Peters, J., Alhasan, S., Vogels, C. B. F., Grubaugh, N. D., Farhadian, S., & Longbrake, E. E. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102857 · Cited by 49 · see citing works

What SARS-CoV-2 does to our brains

Aschman, T., Mothes, R., Heppner, F. L., & Radbruch, H. (2022) · Immunity · doi:10.1016/j.immuni.2022.06.013 · Cited by 47 · see citing works

Cerebral vasculitis of medium-sized vessels as a possible mechanism of brain damage in COVID-19 patients

Lersy, F., Anheim, M., Willaume, T., Chammas, A., Brisset, J., Cotton, F., & Kremer, S. (2020) · Journal of Neuroradiology · doi:10.1016/j.neurad.2020.11.004 · Cited by 47 · see citing works

Neurological disorders after severe pneumonia are associated with translocation of endogenous bacteria from the lung to the brain

Ma, Q., Yao, C., Wu, Y., Wang, H., Fan, Q., Yang, Q., Xu, J., Dai, H., Zhang, Y., Xu, F., et al. (2023) · Science Advances · doi:10.1126/sciadv.adi0699 · Cited by 43 · see citing works

Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature

Stoian, A., Stoian, M., Bajkó, Z., Maier, S., Andone, S. R., Cioflinc, R. A., Moțățăianu, A., Bărcuţean, L., & Bălașa, R. (2022) · Biomedicines · doi:10.3390/biomedicines10040774 · Cited by 42 · see citing works

The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation

Reinhold, D., Farztdinov, V. M., Yan, Y., Meisel, C., Sadlowski, H., Kühn, J., Perschel, F. H., Endres, M., Düzel, E., Vielhaber, S., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02711-2 · Cited by 42 · see citing works

Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic

de Andrade, E. G., Šimončičová, E., Carrier, M., Vecchiarelli, H. A., Robert, M.-È., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.647378 · Cited by 37 · see citing works

COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection

Straburzyński, M., Nowaczewska, M., Budrewicz, S. P., & Waliszewska‐Prosół, M. (2021) · Cephalalgia · doi:10.1177/03331024211040753 · Cited by 39 · see citing works

Provoked seizures and status epilepticus in a pediatric population with COVID‐19 disease

Thongsing, A., Eizadkhah, D., Fields, C., & Ballaban‐Gil, K. R. (2022) · Epilepsia · doi:10.1111/epi.17293 · Cited by 37 · see citing works

Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models

Bauer, L., Lendemeijer, B., Leijten, L. M. E., Embregts, C. W. E., Rockx, B., Kushner, S. A., de Vrij, F. M. S., & van Riel, D. A. J. (2021) · mSphere · doi:10.1128/msphere.00270-21 · Cited by 37 · see citing works

SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t

Lingor, P., Demleitner, A. F., Wolff, A. W., & Feneberg, E. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02500-w · Cited by 35 · see citing works

Herpesvirus and neurological manifestations in patients with severe coronavirus disease

Carneiro, V. C. D. S., Alves‐Leon, S. V., Sarmento, D. J. D. S., Coelho, W. L. D. C. N. P., Moreira, O. C., Salvio, A. L., Ramos, C. H. F., Filho, C. H. F. R., Marques, C. A. B., Gonçalves, J. P. D. C., et al. (2022) · Virology Journal · doi:10.1186/s12985-022-01828-9 · Cited by 35 · see citing works

Biological and Psychological Factors Determining Neuropsychiatric Outcomes in COVID-19

Tizenberg, B., Brenner, L. A., Lowry, C. A., Okusaga, O. O., Benavides, D. R., Hoisington, A. J., Benros, M. E., Stiller, J. W., Kessler, R. C., & Postolache, T. T. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01275-3 · Cited by 33 · see citing works

MOG antibody-associated encephalitis secondary to Covid-19: case report

Durovic, E., Bien, C., Bien, C. G., & Isenmann, S. (2021) · BMC Neurology · doi:10.1186/s12883-021-02449-5 · Cited by 33 · see citing works

Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer’s disease

Chen, J., Chen, J., Lei, Z., Zhang, F., Zeng, L., Wu, X., Li, S., & Tan, J. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02692-z · Cited by 32 · see citing works

What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS‐CoV‐2

Li, Y., Zhang, Y., & Tan, B. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26943 · Cited by 31 · see citing works

SARS-CoV-2 airway infection results in the development of somatosensory abnormalities in a hamster model

Serafini, R. A., Frere, J. J., Zimering, J. H., Giosan, I. M., Pryce, K. D., Golynker, I., Panis, M., Ruiz, A., tenOever, B. R., & Zachariou, V. (2023) · Science Signaling · doi:10.1126/scisignal.ade4984 · Cited by 30 · see citing works

Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis

Edén, A., Simrén, J., Price, R. W., Zetterberg, H., & Gisslén, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15459 · Cited by 28 · see citing works

Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19

Adesse, D., Gladulich, L., Alvarez-Rosa, L., Siqueira, M., Marcos, A. C., Heider, M., Motta, C. S., Torices, S., Toborek, M. J., & Stipursky, J. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00357-5 · Cited by 29 · see citing works

Cerebrospinal fluid findings in COVID-19 indicate autoimmunity

Lucchese, G. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30147-6 · Cited by 29 · see citing works

Potential role of astrocyte angiotensin converting enzyme 2 in the neural transmission of COVID-19 and a neuroinflammatory state induced by smoking and vaping

Zhang, Y., Archie, S. R., Ghanwatkar, Y., Sharma, S., Nozohouri, S., Burks, E., Mdzinarishvili, A., Liu, Z., & Abbruscato, T. J. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00339-7 · Cited by 29 · see citing works

COVID-19 im Alter – Die geriatrische Perspektive

Wirth, R., Becker, C., Djukic, M., Drebenstedt, C., Heppner, H. J., Jacobs, A. H., Meisel, M., Michels, G., Nau, R., Pantel, J., et al. (2021) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-021-01864-0 · Cited by 27 · see citing works

Clinical, cerebrospinal fluid and neuroimaging findings in COVID-19 encephalopathy: a case series

Tuma, R., Guedes, B., Carra, R., Iepsen, B., Rodrigues, J., Camelo-Filho, A. E., Kubota, G., Ferrari, M., Neto, A. S., Oku, M. H. M., et al. (2020) · doi:10.1101/2020.08.28.20181883 · Cited by 26 · see citing works

Neuroinvasive potential of SARS‐CoV2 with neuroradiological and neuropathological findings: is the brain a target or a victim?

Franca, R. A., Ugga, L., Guadagno, E., Russo, D., & De, M. D. B. (2020) · Apmis · doi:10.1111/apm.13092 · Cited by 26 · see citing works

Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism

Leta, V., Boura, I., van Wamelen, D. J., Rodríguez‐Violante, M., Antonini, A., & Chaudhuri, К. R. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.04.004 · Cited by 26 · see citing works

Histopathological Findings in COVID-19 Cases: A Systematic Review

Hammoud, H., Bendari, A., Bendari, T., & Bougmiza, I. M. (2022) · Cureus · doi:10.7759/cureus.25573 · Cited by 25 · see citing works

Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review

Feizi, P., Sharma, K., Pasham, S. R., Nirwan, L., Joseph, J. T., Jaiswal, S., & Sriwastava, S. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577939 · Cited by 25 · see citing works

Brain Organoids: Studying Human Brain Development and Diseases in a Dish

Xu, J., & Wen, Z. (2021) · Stem Cells International · doi:10.1155/2021/5902824 · Cited by 24 · see citing works

Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far

Boura, I., & Chaudhuri, К. R. (2022) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13461 · Cited by 24 · see citing works

Consensus Clinical Guidance for Diagnosis and Management of Adult COVID-19 Encephalopathy Patients

Michael, B. D., Walton, D., Westenberg, E., García‐Azorín, D., Singh, B., Tamborska, A., Netravathi, M., Chomba, M., Wood, G. K., Easton, A., et al. (2021) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.22010002 · Cited by 25 · see citing works

Cerebrospinal fluid analysis in patients with COVID-19-associated central nervous system manifestations: a systematic review

Domingues, R. B., Leite, F. B. V. D. M., & Senne, C. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 21 · see citing works

Review of Neurological Manifestations of SARS-CoV-2

Priyal, P., Sehgal, V., Kapila, S., Taneja, R., Mehmi, P., & Gulati, N. (2023) · Cureus · doi:10.7759/cureus.38194 · Cited by 20 · see citing works

Myoclonus and COVID‐19 : A Challenge for the Present, a Lesson for the Future

Latorre, A., & Rothwell, J. C. (2020) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13103 · Cited by 20 · see citing works

Neuropathogenesis of acute coronavirus disease 2019

Farhadian, S., Seilhean, D., & Spudich, S. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000944 · Cited by 20 · see citing works

Cerebrospinal Analysis in Patients With COVID-19

Miller, E. H., Namale, V. S., Kim, C. F., Dugue, R., Waldrop, G. E., Ciryam, P., Chong, A. M., Zucker, J. E., Miller, E. C., Bain, J., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa501 · Cited by 20 · see citing works

Cerebrospinal fluid analysis in patients with COVID-19-associated central nervous system manifestations: a systematic review

Domingues, R. B., Leite, F. B. V. D. M., & Senne, C. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2021-0117 · Cited by 19 · see citing works

Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis

Schweitzer, F., Kleineberg, N. N., Göreci, Y., Onur, O. A., Franke, C., & Warnke, C. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000930 · Cited by 18 · see citing works

Neurologic manifestations of COVID-19 in critically ill patients: results of the prospective multicenter registry PANDEMIC

Dimitriadis, K. A., Meis, J., Neugebauer, H., Barlinn, K., Neumann, B. H., Gahn, G., Lochner, P., Knier, B., Lindemann, S., Sühs, K., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04080-3 · Cited by 17 · see citing works

Case Report: Identification of SARS-CoV-2 in Cerebrospinal Fluid by Ultrahigh-Depth Sequencing in a Patient With Coronavirus Disease 2019 and Neurological Dysfunction

Xiang, P., Xu, X., Lü, X., Gao, L., Wang, H., Li, Z., Xiong, H., Li, R., Xiong, Y., Pu, L., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.629828 · Cited by 17 · see citing works

Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?

on behalf of the “Cognitive and Behavioral Neurology” Study Group of the Italian Neurological Society, Stracciari, A., Bottini, G., Guarino, M., Magni, E., & Pantoni, L. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05231-0 · Cited by 19 · see citing works

Clinical Implications of COVID-19 Presence in CSF: Systematic Review of Case Reports

Elmakaty, I., Ferih, K., Karen, O., Ouda, A., Elsabagh, A. A., Amarah, A., & Malki, M. I. (2022) · Cells · doi:10.3390/cells11203212 · Cited by 16 · see citing works

Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report

Bozzali, M., Grassini, A., Morana, G., Zotta, M., Cabras, S., Romagnolo, A., Artusi, C. A., Montalenti, E., Rizzone, M. G., Garbossa, D., et al. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05233-y · Cited by 15 · see citing works

Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19

Paris, G. C., de Azevedo, A., Ferreira, A. L. P., Azevedo, Y. M. A. D., Rainho, M. D. A., de Oliveira, G. P., Silva, K. R., Cortez, E. A. C., Stumbo, A. C., de Carvalho, S. N., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119510 · Cited by 15 · see citing works

78-year-old woman with opsoclonus myoclonus ataxia syndrome secondary to COVID-19

Saha, B. K., Saha, S., & Chong, W. H. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-243165 · Cited by 15 · see citing works

SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study

Nersesjan, V., Amiri, M., Nilsson, A. C., Wamberg, C., Jensen, V. V. S., Petersen, C. B., Hejl, A., Lebech, A., Theut, A. M., Jørgensen, C. S., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad274 · Cited by 14 · see citing works

Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia?

Lima, M., Aloizou, A., Siokas, V., Bakirtzis, C., Liampas, I., Tsouris, Z., Bogdanos, D. P., Balogiannis, S., & Dardiotis, E. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0148 · Cited by 33 · see citing works

Association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients

Ramezani, S., Ezzatifar, F., Hojjatipour, T., Hemmatzadeh, M., Shabgah, A. G., Navashenaq, J. G., Aslani, S., Shomali, N., Arabi, M., Babaie, F., et al. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07907-y · Cited by 14 · see citing works

S1-Leitlinie: Neurologische Manifestationen bei COVID-19

Berlit, P. (2020) · DGNeurologie · doi:10.1007/s42451-020-00254-x · Cited by 13 · see citing works

Past to Present, Epidemiology of SARS-CoV-2 Infection and Ways of Treatment: A Review

Uluçay, O., Altunkülah, E., & Alkaşi, Ü. (2022) · Kafkas Journal of Medical Sciences · doi:10.5505/kjms.2022.90757 · Cited by 12 · see citing works

COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation

Hara, M., Kouda, K., Mizoguchi, T., Yokota, Y., Hayashi, K., Gon, Y., & Nakajima, H. (2021) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/23247096211029787 · Cited by 12 · see citing works

Inflammatory leptomeningeal cytokines mediate delayed COVID-19 encephalopathyPreprint

Remšík, J., Wilcox, J. A., Babady, N. E., McMillen, T. A., Vachha, B. A., Halpern, N. A., Dhawan, V., Rosenblum, M. K., Iacobuzio–Donahue, C. A., Avila, E. K., et al. (2020) · medRxiv · doi:10.1101/2020.09.15.20195511 · Cited by 12 · see citing works

Intrinsic factors behind long‐COVID: II. SARS‐CoV‐2, extracellular vesicles, and neurological disorders

El‐Maradny, Y. A., Rubio‐Casillas, A., Mohamed, K. I., Uversky, V. N., & Redwan, E. M. M. M. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30486 · Cited by 11 · see citing works

SARS-Cov-2 Replication in a Blood–Brain Barrier Model Established with Human Brain Microvascular Endothelial Cells Induces Permeability and Disables ACE2-Dependent Regulation of Bradykinin B1 Receptor

Coelho, S. V. A., Souza, G. L. E., Bezerra, B. B., Lima, L. R., Corrêa, I. A., de Almeida, D. V., Silva-Aguiar, R. P., Pinheiro, A. A. S., Sirois, P., Caruso‐Neves, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125540 · Cited by 11 · see citing works

Brain Renin–Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS‐CoV‐2

Ahmadi, S., & Khaledi, S. (2023) · Analytical Cellular Pathology · doi:10.1155/2023/8883492 · Cited by 11 · see citing works

Post-COVID parkinsonism: A scoping review

Polverino, P., Cocco, A., & Albanese, A. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106066 · Cited by 10 · see citing works

Neuroinflammation and Oxidative Stress in Parkinson’s Disease, Alzheimer’s Disease, and COVID-19: Microglia–Neutrophil Interaction

de Araújo, A. B., Azul, F. V. C. S., Carneiro, Y. C., de Sousa, C. N. S., Vasconcelos, S. M. M., Rios, F. J. O., & Leal, L. K. A. M. (2026) · ACS Omega · doi:10.1021/acsomega.5c10397 · Cited by 9 · see citing works

A Systematic Review on Neurological Aspects of COVID-19: Exploring the Relationship Between COVID-19-Related Olfactory Dysfunction and Neuroinvasion

Purja, S., Oh, S., & Kim, E. Y. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.887164 · Cited by 10 · see citing works

Neurological manifestations of COVID-19: with emphasis on Iranian patients

Aslan, C., Nikfarjam, S., Asadzadeh, M., & Jafari, R. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-00964-2 · Cited by 9 · see citing works

Myelin‐oligodendrocyte glycoprotein antibody‐associated optic neuritis following SARS‐CoV ‐2 pneumonia: A case report

Mitarnun, W., Naksanguan, T., Laoharattanahirun, N., Roekrat, P., Kimavaha, S., & Kajornrith, W. (2022) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12595 · Cited by 8 · see citing works

Insights into organoid-based modeling of COVID-19 pathology

Boroojerdi, M. H., Jabry, T. A., Mirarefin, S. M. J., & Albalushi, H. M. A. (2023) · Virology Journal · doi:10.1186/s12985-023-01996-2 · Cited by 8 · see citing works

The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis—A Literature Review

Kulikowska, J., Kulczyńska‐Przybik, A., Mroczko, B., & Kułakowska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115894 · Cited by 7 · see citing works

Neuroimaging in the First 6 Weeks of the COVID-19 Pandemic in an 8-Hospital Campus: Observations and Patterns in the Brain, Head and Neck, and Spine

Kelsch, R. D., Silbergleit, R., & Krishnan, A. S. (2021) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000001179 · Cited by 7 · see citing works

COVID-19 encephalopathy: an unusual presentation with new-onset seizure causing convulsive status epilepticus

Siddiqui, A. F., Saadia, S., Ejaz, T., & Mushtaq, Z. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-245387 · Cited by 7 · see citing works

Association Between COVID-19 and Neurological Diseases: Evidence from Large-Scale Mendelian Randomization Analysis and Single-Cell RNA Sequencing Analysis

Huang, L., Wang, Y., He, Y., Huang, D., Wen, T., & Han, Z. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03975-2 · Cited by 6 · see citing works

Autoantigens of Small Nerve Fibers and Human Coronavirus Antigens: Is There a Possibility for Molecular Mimicry?

Gavrilova, N. Y., Normatov, M. G., Сопрун, Л. А., Utekhin, V. J., Fedotkina, T. V., & Churilov, L. P. (2024) · Current Microbiology · doi:10.1007/s00284-024-03885-5 · Cited by 6 · see citing works

Pseudotumor Cerebri Complicating Multisystem Inflammatory Syndrome in a Child

Divya, K., Chellappan, I., Kanagaraju, V., & Sundaram, P. (2021) · Journal of Current Ophthalmology · doi:10.4103/joco.joco_241_20 · Cited by 6 · see citing works

New-Onset Movement Disorders in COVID-19: Much Ado about Nothing?

Nirenberg, M. J. (2021) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.644 · Cited by 6 · see citing works

Current clinical findings of acute neurological syndromes after SARS‐CoV‐2 infection

Wang, M., Wang, J., Ren, Y. D., Lu, L., Xiong, W., Li, L., Xu, L., Tang, M., Yuan, Y., Xie, Y., et al. (2024) · MedComm · doi:10.1002/mco2.508 · Cited by 4 · see citing works

Dopamine and its precursor levodopa inactivate SARS-CoV-2 main protease by forming a quinoprotein

Hao, M., He, Y., Song, T., Guo, H., Rayman, M. P., & Zhang, J. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.05.008 · Cited by 5 · see citing works

Cerebrospinal fluid analysis of pregnant women at early stages of COVID-19

Sasaki, L. M. P., Fernandes, G. M., da Silva, Â. P., Motta, F., de Siracusa, C. C., Rabelo, I. P., dos Santos, A., França, P. S., Kurizky, P. S., Tristão, R. M., et al. (2022) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2022.03.043 · Cited by 5 · see citing works

Recommendation: Treatment of clinical long COVID encephalopathies with nasal administered mesenchymal stromal cell extracellular vesicles

Askenase, P. W. (2022) · Frontiers in Nanotechnology · doi:10.3389/fnano.2022.987117 · Cited by 5 · see citing works

SARS-CoV-2 RNA detection in cerebrospinal fluid: Presentation of two cases and review of literature

Luis, M. B., Liguori, N. F., López, P. A., & Alonso, R. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100282 · Cited by 17 · see citing works

Neurological Complications in COVID-19 Patients: Can Analysis of Specific Antibodies and Viral RNA in Paired Cerebrospinal Fluid and Serum be Used for Accurate Diagnosis of SARS-CoV-2 Neuroinflammatory Disease? A Case Series

Lauridsen, K. H., Olsen, K. B., Lund, E. L., Jensen, T. Ø., Pedersen, T. I., Harboe, Z. B., Antsupova, V. S., Rasmussen, L. D., Röser, D., Banner, J., et al. (2022) · Clinical Pathology · doi:10.1177/2632010x221139096 · Cited by 2 · see citing works

Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid

Espíndola, O. D. M., Siqueira, M. M., Soares, C., Lima, M. A., Leite, A. C. C. B., Araújo, A., Brandão, C. O., & Silva, M. T. T. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.123 · Cited by 81 · see citing works

CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms

Edén, A., Kanberg, N., Gostner, J. M., Fuchs, D., Hagberg, L., Andersson, L., Lindh, M., Price, R. W., Zetterberg, H., & Gisslén, M. (2020) · Neurology · doi:10.1212/wnl.0000000000010977 · Cited by 147 · see citing works

NEUROLOGICAL IMPACT OF COVID-19 PANDEMIC: LESSONS & CAUTIONS

Dutta, D. (2020) · Royal Book Publishing · doi:10.26524/royal.37.5 · Cited by 6 · see citing works